Advertisement

Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in France and Monaco or involving organisations from these countries.

Total search results: 882 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Protein Sciences–Sanofi: investment, 201707– acquisition $650m upfront + $100m milestones by Sanofi ANNOUNCED 2017-07-11
Amatsigroup–Eurofins: investment, 201707– acquisition €130m plus some residual debt from Ekkio Capital 2017-07-10
Cellnovo–Consilium: public relations, 201707 service existentPR in UK by CSC 2017-07-07
Cellnovo–NewCap: public relations, 201707 service existent IR + PR in France by NewCap 2017-07-07
Cellnovo–SEVERAL: investment, 201707 capital increase €17.5m with 4.07m new shares at €4.3/share (discount of 27.2%) to institutional investors 2017-07-06
Ana Laboratories–Eurofins: investment, 201707 acquisition by Eurofins 2017-07-05
Servier–Mérieux: cell therapy, 201706– collab research viral vectorization techn for allogenic CAR-T cell therapy production w Transgene 2017-06-29
Servier–Plug and Play: digital health, 201706–202005 collab 3y incl WeHealth by Servier and Plug and Play Health & Wellness platform 2017-06-27
Genoma (IT)–Eurofins: investment, 201706 acquisition of Genoma Group Srl by Eurofins 2017-06-26
Cellectis–SEVERAL: investment, 201706– prospectus filed for proposed IPO of 100% sub Calyxt Inc while Cellectis intends to retain majority ownership 2017-06-23
ERICo (SI)–Eurofins: investment, 201706 acquisition of ERICo by Eurofins from Gorenje Group + two other shareholders 2017-06-23
GenSight Biologics–SEVERAL: investment, 201706 capital increase €22.5m €6/share with Europ + US institutional investors 2017-06-22
AlsaChim–Shimadzu: investment, 201706 acquisition €na of 100% of AlsaChim by Shimadzu Europe 2017-06-21
Novacyt–SEVERAL: investment, 201706 capital increase €3m w 3.53m new shares resulting in delution of 16% 2017-06-20
APG Bio (CN)–Genomic Vision: genomic technology, 201706– distribution of molecular combing technology in Greater China by APG Bio 2017-06-19
Onxeo–SEVERAL: investment, 201706 capital increase €15m with 3.5m new shares at €4.25/share to US + European institutional investors 2017-06-19
TxCell–Miltenyi Biotec: lentiviral vector, 201706– supply of lentiviral vector for TxCell’s CAR-Tregs targeting transplant rejection by Lentigen 2017-06-19
Medicxi Ventures–Alphabet: investment, 201706 closing totalling $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Medicxi Ventures–EU (govt): investment, 201706 closing totalling $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Medicxi Ventures–Novartis: investment, 201706 closing totalling $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Medicxi Ventures–SEVERAL: investment, 201706 closing $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Alphora Research–Eurofins: investment, 201706 acquisition of Alphora by Eurofins 2017-06-13
Centogene–Careventures: investment, 201706 financing round Series A totalling €25m incl co-investor Careventures 2017-06-13
Centogene–Crédit Mutuel-CIC: investment, 201706 financing round Series A totalling €25m incl co-investor CIC Capital 2017-06-13
Centogene–DPE Deutsche Private Equity: investment, 201706 financing round Series A totalling €25m incl co-investor DPE 2017-06-13
Centogene–SEVERAL: investment, 201706 financing round Series A €25m led by TVM Capital + incl DPE + Careventures + CIC Capital 2017-06-13
Centogene–TVM: investment, 201706 financing round Series A totalling €25m incl lead investor TVM Capital Life Science 2017-06-13
Mérieux–Kepler Chevreux: investor conference, 201706 supply service Transgene SA presents at Kepler Biotech Days 2017 in Paris 2017-06-09
TxCell–Leucadia: investor conference, 201706 supply service TxCell at Jefferies Global Healthcare Conference 2017 in NY 2017-06-06
GATC Biotech–Eurofins: investment, 201706–201707 acquisition €na of GATC Biotech AG by Eurofins Scientific SE 2017-06-02
Innate Pharma–Novo Group: anti-C5aR antibody, 201706 acquisition ww rights IPH5401 €2.8m cash + €37.2m shares upfront + €370m milestones + royalties 2017-06-02
Innate Pharma–Novo Group: investment, 201706–201707 increase Novo Nordisk share from 10.3% to between 14.6% to 15.8% w €37.2m share issue 2017-06-02
Nab Labs (FI)–Eurofins: investment, 201706 acquisition of Nab Labs Group Oy by Eurofins 2017-06-01
AstraZeneca–Genomic Vision: genomic technology, 201705– collab using FiberVision DNA combing to develop WEE1 kinase inhibitors 2017-05-23
Genomic Vision–Milestones: public relations, 201705 service existent by Milestones 2017-05-23
Genomic Vision–NewCap: public relations, 201705 service existent investor relations by NewCap 2017-05-23
OSE Immunotherapeutics–Selexis: cell line development, 201705– commercial license for access to RCBs from SUREtechnology platform 2017-05-23
CureVac–Informa: investor conference, 201705 supply service CureVac presents at BioEquity Europe 2017 in Paris 2017-05-22
Medigene–Informa: investor conference, 201705 supply service Medigene presents at BioEquity Europe 2017 in Paris 2017-05-22
Probiodrug–Informa: investor conference, 201705 supply service Probiodrug presents at BioEquity Europe 2017 in Paris 2017-05-22
TxCell–Informa: investor conference, 201705 supply service TxCell presents at BioEquity Europe 2017 in Paris 2017-05-22
Boehringer–Anagenesis: drug discovery technology, 201705– excl license to P2MC technology for drug developm for chronic muscle diseases 2017-05-18
Vesalius Biocapital–SEVERAL: investment, 201705 first closing €65m of Vesalius Biocapital III fund 2017-05-15
Theradiag–SEVERAL: investment, 201705 capital increase €4m with 1.75m new shares at €2.3/share 2017-05-12
Sanofi–Exscientia: drug discovery, 201705– strategic research collab up to €250m using AI for bi-specific small-moleulces for metabolic disease 2017-05-09
MVZ für Laboratoriumsmedizin am Hygiene-Institut–Eurofins: investment, 201705– acquisition of Hygel by Eurofins ANNOUNCED 2017-05-04
Vivet Therapeutics–Columbus Venture Partners: investment, 201705 financing round Series A totalling €37.5m incl co-lead investor CVP 2017-05-04
Vivet Therapeutics–Huntsworth: public relations, 201705 service existent by Citigate Dewe Rogerson 2017-05-04
Vivet Therapeutics–Kurma: investment, 201705 financing round Series A totalling €37.5m incl co-investor Kurma Partners 2017-05-04
Vivet Therapeutics–Novartis: investment, 201705 financing round Series A totalling €37.5m incl co-lead investor Novartis Venture Fund 2017-05-04
Vivet Therapeutics–Odlander Fredrikson: investment, 201705 financing round Series A totalling €37.5m incl co-investor HealthCap 2017-05-04
Vivet Therapeutics–Roche: investment, 201705 financing round Series A totalling €37.5m incl co-investor Roche Venture Fund 2017-05-04
Vivet Therapeutics–SEVERAL: investment, 201705 financing round Series A €37.5m led by Novartis Venture Fund + Columbus Venture Partners 2017-05-04
Vivet Therapeutics–Ysios Capital: investment, 201705 financing round Series A totalling €37.5m incl co-investor Ysios Capital 2017-05-04
ImCheck Therapeutics–ATCG Partners: public relations, 201705 service existent by ATCG 2017-05-02
ImCheck Therapeutics–Boehringer: investment, 201705 financing round Series A totalling €20m incl co-lead investor BIVF 2017-05-02
ImCheck Therapeutics–Gimv: investment, 201705 financing round Series A totalling €20m incl co-investor Gimv 2017-05-02
ImCheck Therapeutics–IDI Group: investment, 201705 financing round Series A totalling €20m incl co-lead investor Idinvest 2017-05-02
ImCheck Therapeutics–Kurma: investment, 201705 financing round Series A totalling €20m incl co-lead investor Kurma Partners 2017-05-02
ImCheck Therapeutics–Life Sciences Partners: investment, 201705 financing round Series A totalling €20m incl co-investor LSP 2017-05-02
ImCheck Therapeutics–SEVERAL: investment, 201705 financing round Series A €20m from BIVF + Kurma Partners + Idinvest + Gimv + LSP 2017-05-02
TxCell–France (govt): T cell therapy, 201705– collab expansion €na r+d w Inserm Transfert + Univ Nantes for CAR-Tregs in transplantation + MS 2017-05-02
TxCell–NewCap: public relations, 201705 service existent Investor Relations by NewCap 2017-05-02
EMBL–Enamine: chemical compound library, 201704– collab library synthesis + medical chemistry + biological services for cancer drug research 2017-04-25
Pfizer–Domain Therapeutics: GPCR target discovery, 201704– collab using bioSensAll technology to profile + validate GPCR targets 2017-04-25
Advent France Biotechnology–Advent Venture Partners: fund management, 201704 service existent support by Advent Life Sciences 2017-04-20
Advent France Biotechnology–NewCap: public relations, 201704 service existent by NewCap 2017-04-20
Advent France Biotechnology–SEVERAL: investment, 201704 first closing €64.75m of Advent France Biotechology Seed-Fund I 2017-04-20
Biocartis–Sycomore Asset Management: investment, 201704 acquisition of shares resulting in 5.15% holding of voting rights in Biocartis 2017-04-19
Mérieux–Van Lanschot: investor conference, 201704 supply service Transgene SA presents at Kempen Life Sciences Conference 2017-04-19
EuroPharma–Universal Media Group: investment, 201704 acquisition of EuroPharma by UMG 2017-04-17
Erytech–SEVERAL: investment, 201704 private placement €70.5m with 3m new ordinary shares at €23.5/share 2017-04-12
Mérieux–Huntsworth: public relations, 201704 service existent for Transgene SA by Citigate Dewe Rogerson 2017-04-10
Nanobiotix–SEVERAL: investment, 201704 private placement €25.1m w 1.6m new shares €15.75/share to qualified US + EU investors 2017-04-06
Ahma–Eurofins: investment, 201704 acquisition of 2nd largest Finnish environmental testing lab Ahma Group by Eurofins 2017-04-04
Ramboll–Eurofins: investment, 201704 acquisition of analytical lab business of Ramboll in Finland by Eurofins 2017-04-03
AB Science–SEVERAL: investment, 201703 private placement €19m net €18.43m w 1.24m new shares at €15.3/share 2017-03-31
Nosopharm–SEVERAL: investment, 201703 financing round €2.4m incl new investors Auriga Partners + Kreaxi + Alto Invest + existing investors 2017-03-28
Sofinnova–Strategies & Image: public relations, 201703 service existent by Strategies & Image for Sofinnova Partners 2017-03-28
Institut Pasteur–Bruker Corp: NMR spectrometer, 201703 supply existent early customer for AVANCE NEO 800 MHz system 2017-03-27
VBM Laboratoriet–Eurofins: investment, 201703 acquisition of VBM by Eurofins 2017-03-24
BioClin Therapeutics–Life Sciences Partners: investment, 201703 financing round Series B totalling $30m incl existing investor LSP 2017-03-22
BioClin Therapeutics–Odlander Fredrikson: investment, 201703 financing round Series B totalling $30m incl existing investor HealthCap 2017-03-22
BioClin Therapeutics–SEVERAL: investment, 201703 financing round Series B $30m led by new investors Sofinnova Ventures + Ysios Capital 2017-03-22
BioClin Therapeutics–Sofinnova: investment, 201703 financing round Series B totalling $30m led by new investors Sofinnova Ventures + Ysios Capital 2017-03-22
BioClin Therapeutics–Tekla Capital: investment, 201703 financing round Series B totalling $30m incl existing investor Tekla Capital Management 2017-03-22
BioClin Therapeutics–Ysios Capital: investment, 201703 financing round Series B totalling $30m led by new investors Sofinnova Ventures + Ysios Capital 2017-03-22
Nicox–Oppenheimer: investor conference, 201703 supply service Nicox presents at Oppenheimer Annual Healthcare Conference in New York 2017-03-22
Symetis–SEVERAL: investment, 201703 IPO at Euronext NOT REALISED because of acquistion offer by Boston Scientific 2017-03-17
Gözlem–Eurofins: investment, 201703 acquisition of Gözlem Gýda Kontrol ve Araþtýrma Laboratuvarlarý by Eurofins 2017-03-16
Mechem Laboratories–Eurofins: investment, 201703 acquisition of Mechem by Eurofins 2017-03-15
Hybrigenics–Biofiteam: investment, 201703 management buy-out 75.8% €196k cash + €600k milestones of Hybrigenics Services from Hybrigenics SA 2017-03-13
TxCell–Roth Capital Partners: investor conference, 201703 supply service TxCell presents at Annual Roth Conference 2017 2017-03-12
Galapagos–Pharnext: drug discovery, 201703– collab r+d using Pleotherapy techn to generate new synergistic drug combinations 2017-03-09
Breath Therapeutics–Gimv: investment, 201703 financing round Series A totalling €43.5m incl co-led by Gimv + Sofinnova Partners 2017-03-08
Breath Therapeutics–SEVERAL: investment, 201703 financing round Series A €43.5m co-led by Gimv + Sofinnova Partners 2017-03-08
Breath Therapeutics–Sofinnova: investment, 201703 financing round Series A totalling €43.5m incl co-led by Gimv + Sofinnova Partners 2017-03-08
Cerba–IntegraGen: molecular diagnostics, 201703– license €na to commercialise miR-31-3p tumor expression test in FR + Benelux + MENA 2017-03-08
Orphazyme–SEVERAL: investment, 201703 financing round €14m incl new investors LSP + ALS Investment Fund 2017-03-08
Nicox–Cowen: investor conference, 201703 supply service Nicox presents at Cowen & Co Annual Health Care Conference 2017 2017-03-07
1 2 3 4 5 6 7 8 9  next pagenext page



Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture BIO Deutschland EBDC 2017 Heidelberg 600x60px

» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px